BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26499176)

  • 1. Use of Insulin Lispro Protamine Suspension in Pregnancy.
    Lapolla A; Dalfrà MG; Romoli E; Bonomo M; Moghetti P
    Adv Ther; 2015 Oct; 32(10):888-905. PubMed ID: 26499176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic pregnancy outcomes in mothers treated with basal insulin lispro protamine suspension or NPH insulin: a multicenter retrospective Italian study.
    Dalfrà MG; Soldato A; Moghetti P; Lombardi S; Vinci C; De Cata AP; Romanelli T; Bonomo M; Sciacca L; Tata F; Ragazzi E; Filippi A; Burlina S; Lapolla A
    J Matern Fetal Neonatal Med; 2016; 29(7):1061-5. PubMed ID: 25817082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial.
    Koivisto V; Cleall S; Pontiroli AE; Giugliano D
    Diabetes Obes Metab; 2011 Dec; 13(12):1149-57. PubMed ID: 21819517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a prospective randomized open-label trial.
    Arakaki RF; Blevins TC; Wise JK; Liljenquist DR; Jiang HH; Jacobson JG; Martin SA; Jackson JA
    Diabetes Obes Metab; 2014 Jun; 16(6):510-8. PubMed ID: 24298995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin lispro protamine suspension in the treatment of patients with type 1 and type 2 diabetes mellitus: a systematic review of published data.
    Ceriello A; Cremasco F; Romoli E; Rossi A; Gentilella R
    Expert Opin Pharmacother; 2012 Feb; 13(2):255-81. PubMed ID: 22242803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.
    Bowering K; Reed VA; Felicio JS; Landry J; Ji L; Oliveira J
    Diabet Med; 2012 Sep; 29(9):e263-72. PubMed ID: 22672081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women.
    Mecacci F; Carignani L; Cioni R; Bartoli E; Parretti E; La Torre P; Scarselli G; Mello G
    Eur J Obstet Gynecol Reprod Biol; 2003 Nov; 111(1):19-24. PubMed ID: 14557006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal supplementation of insulin lispro protamine suspension versus insulin glargine and detemir for type 2 diabetes: meta-analysis of randomized controlled trials.
    Esposito K; Chiodini P; Capuano A; Petrizzo M; Improta MR; Giugliano D
    Diabetes Care; 2012 Dec; 35(12):2698-705. PubMed ID: 23173139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes.
    Herrera KM; Rosenn BM; Foroutan J; Bimson BE; Al Ibraheemi Z; Moshier EL; Brustman LE
    Am J Obstet Gynecol; 2015 Sep; 213(3):426.e1-7. PubMed ID: 26070699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes.
    Giugliano D; Esposito K
    Ther Adv Endocrinol Metab; 2012 Jun; 3(3):99-108. PubMed ID: 23148201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The care of pregestational and gestational diabetes and drug metabolism considerations.
    Hedrington MS; Davis SN
    Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1029-1038. PubMed ID: 28847172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of insulin lispro during pregnancy in women with pregestational diabetes mellitus.
    García-Domínguez M; Herranz L; Hillman N; Martín-Vaquero P; Jáñez M; Moya-Chimenti E; Pallardo LF
    Med Clin (Barc); 2011 Nov; 137(13):581-6. PubMed ID: 21376350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics.
    Fang YM; MacKeen D; Egan JF; Zelop CM
    J Matern Fetal Neonatal Med; 2009 Mar; 22(3):249-53. PubMed ID: 19330710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin glargine versus neutral protamine Hagedorn insulin for treatment of diabetes in pregnancy.
    Smith JG; Manuck TA; White J; Merrill DC
    Am J Perinatol; 2009 Jan; 26(1):57-62. PubMed ID: 18979406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
    Durnwald CP; Landon MB
    J Matern Fetal Neonatal Med; 2008 May; 21(5):309-13. PubMed ID: 18446657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humalog (lispro) for type 2 diabetes.
    Esposito K; Capuano A; Giugliano D
    Expert Opin Biol Ther; 2012 Nov; 12(11):1541-50. PubMed ID: 23043233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulins and oral hypoglycemic agents in pregnancy.
    Homko CJ; Reece EA
    J Matern Fetal Neonatal Med; 2006 Nov; 19(11):679-86. PubMed ID: 17127490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?
    Lapolla A; Dalfrà MG; Fedele D
    Diabetes Metab Res Rev; 2005; 21(3):241-52. PubMed ID: 15818714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.